Ferrer has announced that its FAB122 failed to achieve its primary efficacy and ...
Germany’s Federal Ministry of Health has published its evaluation report on the ...
In late 2023, Vertex Pharmaceuticals and CRISPR Therapeutics made history by gai...
Musk announced Neuralink's first sucessful human BCI implant on Sunday, but can ...
Astellas has submitted an sNDA in Japan seeking approval for PADCEV with KEYTRUD...
CMS’ CGT Access Model will see allow the agency to negotiate negotiate pricing a...
The FDA has granted an orphan drug designation to Revolo’s ‘1104, with plans for...
As the UK pharmaceutical sector adopts the VPAG scheme, the question of how this...
The NASA and US Navy-propelled company remains confident, with Defender CEO Barr...
The shelving of Biogen’s troubled Alzheimer’s drug caps a turbulent journey, wit...
Trial results for a pain medication developed by Vertex Pharmaceuticals prompted...
The U.S. government announced a long-awaited “access model” designed to blunt th...
The U.S. syphilis epidemic isn't abating, with the rate of infectious cases risi...
Never mind Kendall Square. In Massachusetts, the next miracle drug for lung canc...
Philips won't be able to sell new sleep apnea machines until it meets corrective...
Want to stay on top of the science and politics driving biotech today? Sign up t...
